Tag Archives: First

Winners announced for the first ever 2020 North American Inspiring Workplaces Awards

Formerly known as The Employee Engagement Awards, now operating as The Inspiring Workplaces Awards Winners include organizations such as Cisco, Merck, Northwell Health, State of Colorado, T-Mobile, VA North Texas, Western Union Open for entries around the world for The 2021 Inspiring Workplaces Awards New York – September 24, 2020 – The 2020 North American… Read More »

‘Vampire’ parasite pretends to be fish’s tongue — but only after eating it first

Grusome photos of a blood-thirsty parasite living in the mouth of a fish having devoured its host’s tongue have surfaced online. Posted to social media by a scientist this week, the X-ray scans show an isopod, also known as tongue-eating louse, nestled in the skull of a wrasse. The 4cm-long “vampire” crustacean invades its host… Read More »

Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis

Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »

A trial is under way of the first new antibody medicine developed to treat covid-19 – MIT Technology Review

The news: Patients have started to receive the first antibody drug developed specifically to treat covid-19. It’s being tested in 32 patients at various doses in hospitals in the US. If it’s shown to be safe, the drug, referred to as LY-CoV555, will be studied in non-hospitalized coronavirus patients later this summer. The big idea:… Read More »

First map of tumour microbiomes finds bacteria live in many cancers

By Alice Klein More than 60 per cent of pancreatic tumours tested positive for bacterial DNAANNE WESTON, FRANCIS CRICK INSTITUTE / SCIENCE PHOTO LIBRARY The first comprehensive survey of the microorganisms that live inside tumours has found that bacteria reside in those from many different cancer types, but it is unclear whether they contribute to… Read More »

FDA Approves Dupixent (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis

Print this page TARRYTOWN, N.Y. and PARIS, May 26, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not… Read More »